Compare CETX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CETX | SPRC |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 4.0M |
| IPO Year | 1998 | N/A |
| Metric | CETX | SPRC |
|---|---|---|
| Price | $2.22 | $1.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.5M | 3.5M |
| Earning Date | 12-19-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,095,551.00 | $1,306,000.00 |
| Revenue This Year | $19.77 | N/A |
| Revenue Next Year | $15.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.50 | ★ 187.98 |
| 52 Week Low | $2.16 | $1.52 |
| 52 Week High | $55.50 | $37.59 |
| Indicator | CETX | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 41.57 | 30.71 |
| Support Level | $2.16 | $1.55 |
| Resistance Level | $2.47 | $1.71 |
| Average True Range (ATR) | 0.98 | 0.21 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 0.53 | 0.00 |
Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.